CurrentEndo
Get Weekly

Topic · page 59 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 2,321–2,360 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabet Med

    Designing a regional clinical service for people with early‐onset type 2 diabetes in England

    Research article

  2. Diabetologia

    A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular–kidney complications

    Diagnostic or prognostic study

  3. Diabetes Care

    Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL

    Secondary analysis

  4. Cardiovasc Diabetol

    The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better

    Cohort study

  5. Int J Obes (Lond)

    Association between weight changes and infective endocarditis in patients with diabetes: A nationwide population-based cohort study

    Cohort study

  6. Diabetes Care

    Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study

    Randomized controlled trial

  7. Cardiovasc Diabetol

    Combined impact of prediabetes and hepatic steatosis on cardiometabolic outcomes in young adults

    Cohort study

  8. Cardiovasc Diabetol

    SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)

    Cohort study

  9. Diabetes Obes Metab

    One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA

    Meta-analysis

  10. Diabetes Res Clin Pract

    The impact of ethnicity and its definition on diabetes prevalence: A national Australian whole-of-population study

    Cross-sectional study

  11. J Clin Endocrinol Metab

    Serum Metabolomic Profiling of Incident Type 2 Diabetes Mellitus in the Multi-ethnic Study of Atherosclerosis and Rotterdam Study

    Cohort study

  12. Diabetes Care

    Cost-effectiveness of the National Diabetes Prevention Program: A Real-world, 2-Year Prospective Study

    Cohort study

  13. Diabetes Obes Metab

    Incidence of diabetes mellitus following hospitalisation for COVID ‐19 in the United Kingdom: A prospective observational study

    Cohort study

  14. Diabetes Obes Metab

    Relationship between trajectory of Chinese visceral adiposity index and risk of type 2 diabetes mellitus: Evidence from the China ‐ PAR project

    Cohort study

  15. Obesity (Silver Spring)

    Sex differences in ectopic lipid deposits and cardiac function across a wide range of glycemic control: a secondary analysis

    Secondary analysis

  16. Diabetes Care

    Associations of Clinical Characteristics With Sudden Cardiac Arrest in People With Type 2 Diabetes With and Without Cardiovascular Disease: A Longitudinal Case-Control Study Using Routine Primary Care Data

    Case-control study

  17. Cardiovasc Diabetol

    Associations of baseline and changes in the triglyceride glucose-weight adjusted waist index and cardiovascular disease risk: evidence from middle-aged and older individuals

    Cohort study

  18. Diabetes Res Clin Pract

    SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysis

    Meta-analysis

  19. Diabetes Res Clin Pract

    Target gene variations of PPAR isoforms may contribute to MODY heterogeneity: A preliminary comparative study with type 2 diabetes

    Research article

  20. Diabetes Res Clin Pract

    Global, regional, and national burden of type 2 diabetes mellitus attributable to particulate matter pollution from 1990 to 2021: An analysis of the global burden of disease study 2021

    Secondary analysis

  21. N Engl J Med

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes

    Randomized controlled trial

  22. Diabetes Care

    Trends in Peripheral Artery Disease, Lower-Extremity Revascularization, and Lower-Extremity Amputation in Incident Type 2 Diabetes: A Danish Population-Based Cohort Study

    Cohort study

  23. Cardiovasc Diabetol

    The mediatory role of androgens on sex differences in glucose homeostasis and incidence of type 2 diabetes: the KORA study

    Cohort study

  24. Cardiovasc Diabetol

    Lipophilic index of serum phospholipids in patients with type 2 diabetes and atherosclerotic cardiovascular disease: links with metabolic control, vascular inflammation and platelet activation

    Cross-sectional study

  25. BMJ Open Diabetes Res Care

    Widening the phenotypic spectrum caused by pathogenic PDX1 variants in individuals with neonatal diabetes

    Cohort study

  26. Cardiovasc Diabetol

    Low-frequency variants in genes involved in glutamic acid metabolism and γ-glutamyl cycle and risk of coronary artery disease in type 2 diabetes

    Research article

  27. Lancet

    Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants

    Meta-analysis

  28. J Clin Endocrinol Metab

    Enhanced Outcomes in Type 2 Diabetes Patients With Acute Kidney Disease Through Thiazolidinedione

    Cohort study

  29. Diabetes Res Clin Pract

    Real world effectiveness of oral semaglutide: Focus on patients with type 2 diabetes older than 75 years

    Cohort study

  30. Diabetes Res Clin Pract

    Adequate sleep duration accentuates the effect of glucagon-like peptide-1 receptor variant on HbA1c: A gene-environment interaction study

    Research article

  31. Diabetes Res Clin Pract

    The prognostic significance of diabetes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis

    Meta-analysis

  32. Diabetes Care

    Life Course Associations Between Ambient Fine Particulate Matter and the Prevalence of Prediabetes and Diabetes: A Longitudinal Cohort Study in Taiwan and Hong Kong

    Cohort study

  33. Diabetes Res Clin Pract

    Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: A propensity score-matched study

    Cohort study

  34. Diabetologia

    Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes

    Cohort study

  35. Diabetologia

    Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes

    Cohort study

  36. Diabetes Obes Metab

    De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial ( TRANSITION ‐ T2D )

    Randomized controlled trial

  37. Diabet Med

    Diabetes distress and depression in type 2 diabetes. A cross‐sectional study in 18,000 individuals in the Central Denmark region

    Cross-sectional study

  38. Diabetes Obes Metab

    Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria

    Cross-sectional study

  39. Lancet Diabetes Endocrinol

    Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium

    Cohort study

  40. Diabetes Technol Ther

    Impact of Continuous Glucose Monitoring Versus Blood Glucose Monitoring to Support a Carbohydrate-Restricted Nutrition Intervention in People with Type 2 Diabetes

    Randomized controlled trial

All 4,758 Briefs in ExploreShowing Briefs 2,321–2,360 of 4,758, newest first